InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Hirawat Samit, Directeur Médical. Insider active across 1 company, notably Bristol Myers Squibb Co. In total, 11 disclosures have been published. Split: 3 buys · 0 sell. Total volume traded: €365k. History available since 1 July 2021. The latest transaction was filed on 25 April 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
4,250 shares@ US$47.5848.7% of flowCommon Stock, $0.10 par valueSEC:0000014272-25-000093:0
Ideal exit: 20 Jan 2026 (T+270)
4,886 shares0Common Stock, $0.10 par valueSEC:0000014272-25-000063:0
1,823.486 shares@ US$54.8426.2% of flowCommon Stock, $0.10 par valueSEC:0000014272-25-000041:0
Ideal exit: 11 Nov 2025 (T+270)
1,830 shares@ US$54.67525.2% of flowCommon Stock, $0.10 par valueSEC:0000014272-24-000149:0
Ideal exit: 29 Jul 2025 (T+270)
4,192 shares0Common Stock, $0.10 par valueSEC:0000014272-24-000070:0
9,357 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000128:0
4,189 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000064:0
9,356 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000154:0
4,189 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000072:0
9,356 shares0Common Stock, $0.10 par valueSEC:0000014272-21-000182
9,356 shares0Common Stock, $0.10 par valueSEC:0000014272-21-000182:0
11 of 11 declarations
About Hirawat Samit
Samit Hirawat is Executive Vice President and Chief Medical Officer, Drug Development at BRISTOL MYERS SQUIBB CO. He oversees drug research and development initiatives. His expertise is essential in ensuring innovation and safety in the treatments offered.
